164 related articles for article (PubMed ID: 8765621)
1. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center.
Ozsahin H; Le Deist F; Benkerrou M; Cavazzana-Calvo M; Gomez L; Griscelli C; Blanche S; Fischer A
J Pediatr; 1996 Aug; 129(2):238-44. PubMed ID: 8765621
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome.
Rumelhart SL; Trigg ME; Horowitz SD; Hong R
Blood; 1990 Feb; 75(4):1031-5. PubMed ID: 2302455
[TBL] [Abstract][Full Text] [Related]
5. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report.
Fischer A; Friedrich W; Fasth A; Blanche S; Le Deist F; Girault D; Veber F; Vossen J; Lopez M; Griscelli C
Blood; 1991 Jan; 77(2):249-56. PubMed ID: 1985691
[TBL] [Abstract][Full Text] [Related]
6. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.
Kobayashi R; Ariga T; Nonoyama S; Kanegane H; Tsuchiya S; Morio T; Yabe H; Nagatoshi Y; Kawa K; Tabuchi K; Tsuchida M; Miyawaki T; Kato S
Br J Haematol; 2006 Nov; 135(3):362-6. PubMed ID: 17032176
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
8. Unrelated donor BMT for Wiskott-Aldrich syndrome.
Lenarsky C; Weinberg K; Kohn DB; Parkman R
Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361
[TBL] [Abstract][Full Text] [Related]
9. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.
Filipovich AH; Stone JV; Tomany SC; Ireland M; Kollman C; Pelz CJ; Casper JT; Cowan MJ; Edwards JR; Fasth A; Gale RP; Junker A; Kamani NR; Loechelt BJ; Pietryga DW; Ringdén O; Vowels M; Hegland J; Williams AV; Klein JP; Sobocinski KA; Rowlings PA; Horowitz MM
Blood; 2001 Mar; 97(6):1598-603. PubMed ID: 11238097
[TBL] [Abstract][Full Text] [Related]
10. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated lymphoproliferative disorder after unrelated bone marrow transplantation in a young child with Wiskott-Aldrich syndrome.
Sasahara Y; Kawai S; Itano M; Kumaki S; Fujie H; Minegishi M; Tsuchiya S; Konno T
Pediatr Hematol Oncol; 1998; 15(4):347-52. PubMed ID: 9658436
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse.
Cavazzana-Calvo M; Bordigoni P; Michel G; Esperou H; Souillet G; Leblanc T; Stephan JL; Vannier JP; Mechinaud F; Reiffers J; Vilmer E; Landman-Parker J; Benkerrou M; Baruchel A; Pico J; Bernaudin F; Bergeron C; Plouvier E; Thomas C; Wijdenes J; Lacour B; Blanche S; Fischer A
Br J Haematol; 1996 Apr; 93(1):131-8. PubMed ID: 8611446
[TBL] [Abstract][Full Text] [Related]
13. In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemia.
Cavazzana-Calvo M; Jabado N; Bordigoni P; Michel G; Haddad E; Mechinaud F; Landman-Parker J; Leblanc T; Plouvier E; Baruchel A; Stephan JL; Souillet G; Vilmer E; Wijdenes J; Le Deist F; Fischer A
Leuk Lymphoma; 1997 Dec; 28(1-2):103-12. PubMed ID: 9498709
[TBL] [Abstract][Full Text] [Related]
14. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
Rosales F; Peylan-Ramu N; Cividalli G; Varadi G; Or R; Naparstek E; Slavin S; Nagler A
Bone Marrow Transplant; 1999 May; 23(9):861-5. PubMed ID: 10338039
[TBL] [Abstract][Full Text] [Related]
15. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI
Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353
[TBL] [Abstract][Full Text] [Related]
16. CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center.
Gennery AR; Dickinson AM; Brigham K; Barge D; Spickett GP; Curtis A; Spencer V; Jackson A; Cavanagh G; Carter V; Palmer P; Flood TJ; Cant AJ; Abinun M
Cytotherapy; 2001; 3(3):221-32. PubMed ID: 12171729
[TBL] [Abstract][Full Text] [Related]
17. Successful bone marrow transplantation in a Chinese boy with Wiskott-Aldrich syndrome.
Huang MT; Chou CC; Jou ST; Lin KH; Hsieh KH
Asian Pac J Allergy Immunol; 1996 Jun; 14(1):57-63. PubMed ID: 8980801
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Omenn syndrome by bone marrow transplantation.
Gomez L; Le Deist F; Blanche S; Cavazzana-Calvo M; Griscelli C; Fischer A
J Pediatr; 1995 Jul; 127(1):76-81. PubMed ID: 7608815
[TBL] [Abstract][Full Text] [Related]
19. Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome.
Brochstein JA; Gillio AP; Ruggiero M; Kernan NA; Emanuel D; Laver J; Small T; O'Reilly RJ
J Pediatr; 1991 Dec; 119(6):907-12. PubMed ID: 1960605
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group.
Gerritsen EJ; Vossen JM; Fasth A; Friedrich W; Morgan G; Padmos A; Vellodi A; Porras O; O'Meara A; Porta F
J Pediatr; 1994 Dec; 125(6 Pt 1):896-902. PubMed ID: 7996361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
